Biotechnology

Genetic Engineering Drug Development Genetics Nanotechnology Vaccine Development Pharmaceuticals Gene Therapy Research and Development Gene Editing Tissue Engineering

Anthropic Reportedly Buys Coefficient Bio in $400 Million All-Stock Deal

The reported deal signals Anthropic’s push into life sciences ahead of a possible IPO.

Lab-Grown ‘T. Rex Leather’ Handbag Unveiled in Amsterdam Ahead of Auction

Peer-Reviewed Study Validates Six-Hour Urine Test for Targeted UTI Treatment

Engineered Tobacco Plant Produces Five Psychedelic Compounds

Franco-Japanese Team Demos DNA-Based One-Time Pad Encryption in Tokyo

Cyclerion to Merge With Korsana in Reverse Takeover Backed by $380 Million

Lilly Strikes $2.75 Billion Deal for Insilico’s AI-Designed Oral Drugs

Wireless Implant Works as a Living Pharmacy, Sustaining Multi‑Drug Delivery in Rats

PTAB Reaffirms Broad Institute’s Priority for CRISPR-Cas9 in Eukaryotic Cells

DBV Technologies Files 2025 Annual Report, Extends Runway as 2026 Peanut Patch Filings Near

Wave Life Sciences Shares Plunge 30% After Early Obesity Trial Readout

Engineered mRNA Nanoparticles Reroute Delivery to Lymph Nodes in Mouse Study

Sanofi Licenses Kali’s Tri-Specific Autoimmune Antibody KT501 in Deal Worth Up to $1.23 Billion

Gilead to Buy Ouro Medicines for $1.675 Billion Upfront to Advance Autoimmune T‑Cell Engager

Japanese Team Reports Oral Insulin Success in Mice With Peptide Transporter

RTW Buys $116 Million of Cogent Biosciences as Kynam Trims $48 Million Stake

Peer-Reviewed Study Shows Lab-Grown Oesophagus Restores Swallowing in Pigs

Novartis Strikes $2 Billion Deal for Mutant-Selective PI3Kα Cancer Drug SNV4818

Humacyte Raises $20 Million in Direct Offering and Lands Saudi Symvess Purchase Pact

Australian Dog’s AI-Assisted mRNA Cancer Shot Shows Early Gains, Not Proof of a Cure